EC Healthcare Opens New Multi-Service Flagship Medical Center at Taikoo Central Advanced Imaging Center


HONG KONG, April 4, 2022 – (ACN Newswire) – – EC Health (the “Company”, which together with its subsidiaries is referred to as the “Group”, stock code SEHK: 2138), the largest non-hospital medical group in hong kong*, is pleased to announce that the Group’s new multi-service flagship medical center (“New Flagship Centre”) located in Central and its new Advanced Imaging Center located in Tai Koo started operations on March 31, 2022 and April 1, 2022 respectively, thereby expanding the Group’s market share in the medical market.

The new flagship center is located at Fung House in Central, Hong Kong Island, with seven new floors with a total gross floor area of ​​approximately 22,000 square feet. The top five floors of the new flagship center offer services including but not limited to general medicine, orthopedics, ophthalmology, chiropractic, physiotherapy and pain management and service centers started their activities. The other two floors will be an Advanced Imaging Center serving as a one-stop medical imaging service center, which is expected to go live in the fourth quarter of 2022.

Additionally, the gross floor area of ​​another new Advanced Imaging Center is located at 6/F Cityplaza at Tai Koo, Hong Kong Island is approximately 3,400 square feet. After this expansion, the Group operates six state-of-the-art imaging centers in the New Territories, Kowloon and Hong Kong Islandthereby further improving its service network.

Sir. Eddy TangChairman, Managing Director and Chief Executive Officer of EC Health noted, “EC Health develops preventive and precision medicine as its core business. To meet the strong demand for medical services, the Group has set up the associated service centers through organic growth in order to further exploit the commercial synergy between its diversified medical and health activities. The Group will remain committed to building a closed healthcare ecosystem focused on customer satisfaction in order to provide quality one-stop-shop services to customers and consolidate the Group’s leadership in the industry as a provider of medical services and one-stop comprehensive health care. »

On EC Health

EC Health East that of Hong Kong leading provider of non-hospital medical services*, relying on its core businesses of preventive and precision medicine, and committed to the development of medical artificial intelligence by integrating its multidisciplinary medical services. This decision, which is based on the Group’s high-end brand image and quality customer services, aims to provide customers with safe and efficient health care and medical services with professionalism. The Group is part of the MSCI Small Cap index and the Hang Seng Composite index.

The Group mainly engages in the provision of one-stop medical and healthcare services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop provider of aesthetic medical solutions DR REBORN which ranked first in hong kong by sales for years, primary care clinics established jointly with Tencent Doctorate, SPINE Central Chiropractic Service Center, New York Spine and Physiotherapy Center NYMG, re:HEALTH Health Management Center, Hong Kong Professional Vaccine HKPV, UMH DENTAL CARE Comprehensive Dental Center, Diagnostic Center and HKAI imaging center, an oncology treatment center reVIVE, a day procedure center HKMED, a specialist clinic SPECIALIST CENTER and NEW MEDICAL CENTER, specialist in obstetrics and gynecology ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSTIC CENTER, specialist center, a center pediatric PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratoriesa professional hair care center HAIR FOREST, VIVID EYE ophthalmology center and CE Veterinary Hospital and imaging center.

*According to an independent study conducted by Frost and Sullivan in terms of turnover in 2019 and 2020

For more information, please contact:

iPR Ogilvy Limited

Callis Lau / Lorraine Luk / Charmaine IP

Tel: (852) 2136 6952 / 2169 0467 / 3920 7649

Fax: (852) 3170 6606


Copyright 2022 ACN Newswire. All rights reserved.

© Japan Corporate News, source JCN Press Releases


Comments are closed.